Geode Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,460,684
| Closed | -$18M | – | 4550 |
|
|
2024
Q4 | $18M | Sell |
1,460,684
-5,471
| -0.4% | -$62.7K | ﹤0.01% | 2020 |
|
|
2024
Q3 | $16.7M | Buy |
1,466,155
+34,328
| +2% | +$345K | ﹤0.01% | 2075 |
|
|
2024
Q2 | $10.2M | Buy |
1,431,827
+41,886
| +3% | +$320K | ﹤0.01% | 2314 |
|
|
2024
Q1 | $9.31M | Buy |
1,389,941
+42,766
| +3% | +$294K | ﹤0.01% | 2370 |
|
|
2023
Q4 | $8.76M | Buy |
1,347,175
+65,439
| +5% | +$422K | ﹤0.01% | 2415 |
|
|
2023
Q3 | $12.1M | Buy |
1,281,736
+18,263
| +1% | +$220K | ﹤0.01% | 2138 |
|
|
2023
Q2 | $17.7M | Buy |
1,263,473
+51,546
| +4% | +$879K | ﹤0.01% | 1937 |
|
|
2023
Q1 | $22.7M | Buy |
1,211,927
+56,401
| +5% | +$926K | ﹤0.01% | 1712 |
|
|
2022
Q4 | $15.9M | Buy |
1,155,526
+39,812
| +4% | +$610K | ﹤0.01% | 1926 |
|
|
2022
Q3 | $21.3M | Buy |
1,115,714
+6,955
| +0.6% | +$127K | ﹤0.01% | 1683 |
|
|
2022
Q2 | $16.9M | Buy |
1,108,759
+7,974
| +0.7% | +$118K | ﹤0.01% | 1872 |
|
|
2022
Q1 | $22.4M | Sell |
1,100,785
-2,610
| -0.2% | -$53.1K | ﹤0.01% | 1814 |
|
|
2021
Q4 | $32.2M | Buy |
1,103,395
+103,147
| +10% | +$2.95M | ﹤0.01% | 1641 |
|
|
2021
Q3 | $21.6M | Buy |
1,000,248
+7,561
| +0.8% | +$183K | ﹤0.01% | 1908 |
|
|
2021
Q2 | $25.5M | Buy |
992,687
+53,821
| +6% | +$1.15M | ﹤0.01% | 1801 |
|
|
2021
Q1 | $17.1M | Buy |
938,866
+126,008
| +16% | +$2.09M | ﹤0.01% | 1973 |
|
|
2020
Q4 | $9.38M | Buy |
812,858
+43,073
| +6% | +$394K | ﹤0.01% | 2225 |
|
|
2020
Q3 | $5.87M | Buy |
769,785
+10,657
| +1% | +$80.7K | ﹤0.01% | 2299 |
|
|
2020
Q2 | $4.98M | Buy |
759,128
+18,439
| +2% | +$103K | ﹤0.01% | 2342 |
|
|
2020
Q1 | $3.78M | Buy |
740,689
+42,493
| +6% | +$257K | ﹤0.01% | 2296 |
|
|
2019
Q4 | $5.36M | Sell |
698,196
-29,676
| -4% | -$173K | ﹤0.01% | 2411 |
|
|
2019
Q3 | $3.86M | Buy |
727,872
+36,579
| +5% | +$227K | ﹤0.01% | 2539 |
|
|
2019
Q2 | $3.87M | Buy |
691,293
+98,201
| +17% | +$405K | ﹤0.01% | 2548 |
|
|
2019
Q1 | $2.52M | Buy |
593,092
+65,320
| +12% | +$266K | ﹤0.01% | 2712 |
|
|
2018
Q4 | $2.16M | Buy |
527,772
+27,685
| +6% | +$144K | ﹤0.01% | 2730 |
|
|
2018
Q3 | $3.43M | Buy |
500,087
+33,444
| +7% | +$198K | ﹤0.01% | 2598 |
|
|
2018
Q2 | $1.83M | Buy |
466,643
+240,967
| +107% | +$836K | ﹤0.01% | 2906 |
|
|
2018
Q1 | $658K | Sell |
225,676
-225,676
| -50% | -$697K | ﹤0.01% | 3302 |
|
|
2017
Q4 | $1.75M | Buy |
451,352
+225,676
| +100% | +$967K | ﹤0.01% | 2830 |
|
|
2017
Q3 | $709K | Buy |
225,676
+1
| +0% | +$4 | ﹤0.01% | 3244 |
|
|
2017
Q2 | $960K | Buy |
225,675
+20,319
| +10% | +$83.2K | ﹤0.01% | 3122 |
|
|
2017
Q1 | $940K | Buy |
205,356
+49,259
| +32% | +$165K | ﹤0.01% | 3047 |
|
|
2016
Q4 | $336K | Buy |
156,097
+293
| +0.2% | +$685 | ﹤0.01% | 3415 |
|
|
2016
Q3 | $468K | Buy |
155,804
+73
| +0% | +$196 | ﹤0.01% | 3275 |
|
|
2016
Q2 | $396K | Sell |
155,731
-43,474
| -22% | -$121K | ﹤0.01% | 3319 |
|
|
2016
Q1 | $586 | Buy |
199,205
+25,764
| +15% | +$138K | ﹤0.01% | 3143 |
|
|
2015
Q4 | $1.42M | Buy |
173,441
+5,607
| +3% | +$45.3K | ﹤0.01% | 2697 |
|
|
2015
Q3 | $1.2M | Buy |
167,834
+11,138
| +7% | +$93K | ﹤0.01% | 2768 |
|
|
2015
Q2 | $1.44M | Buy |
156,696
+7,485
| +5% | +$72K | ﹤0.01% | 2700 |
|
|
2015
Q1 | $1.41M | Buy |
149,211
+6,513
| +5% | +$62.7K | ﹤0.01% | 2669 |
|
|
2014
Q4 | $1.39M | Buy |
142,698
+2,311
| +2% | +$23.3K | ﹤0.01% | 2644 |
|
|
2014
Q3 | $1.34M | Buy |
140,387
+147
| +0.1% | +$1.65K | ﹤0.01% | 2607 |
|
|
2014
Q2 | $1.84M | Buy |
140,240
+24,599
| +21% | +$310K | ﹤0.01% | 2419 |
|
|
2014
Q1 | $1.54M | Buy |
115,641
+29,898
| +35% | +$394K | ﹤0.01% | 2503 |
|
|
2013
Q4 | $834K | Buy |
85,743
+1,954
| +2% | +$18.4K | ﹤0.01% | 2828 |
|
|
2013
Q3 | $827K | Buy |
83,789
+12,929
| +18% | +$128K | ﹤0.01% | 2700 |
|
|
2013
Q2 | $640K | Buy |
+70,860
| New | +$743K | ﹤0.01% | 2731 |
|
Other funds holding CDMO
Geode Capital Management's CDMO Position: Q1 2025 in Review
Geode Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 1,460,684 shares — an estimated $18M sold.
Geode Capital Management first reported a position in CDMO in Q2 2013 and held it in 47 quarters. The position peaked at $32.2M in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Geode Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Geode Capital Management sold 1,460,684 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $18M.
- Geode Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 47 quarters.
- Geode Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $32.2M in Q4 2021.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.